Function of plasma and microsomal enzymes in Soman toxicity

被引:12
作者
Tuovinen, K [1 ]
机构
[1] Univ Kuopio, Dept Physiol, SF-70211 Kuopio, Finland
关键词
soman; physostigmine; microsonial carboxylesterases; CYP450 isoforms (P4501A and P4502B);
D O I
10.1081/DCT-120027900
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
Such organophosphorous (OP) nerve agents as sarin (isopropyl methylphosphonofluoridate) and soman (pinacolyl rnethylphosphonofluoridate) are effective inhibitors of acetylcholinesterases (AChE), butyrylcholinestcrases (BChE) and carboxylesterases (CaE). The acute toxicity of these compounds in mammals is known to be mediated through inhibition of AChEs, which leads to increased acetylcholine (ACh) levels. The aim of this Study was to compare the significance of the plasma CaEs, microsomial CaEs and CYP450 enzymes in detoxification of soman with and without physostigmine treatment. The mice received physostigmine (0.1 mg/kg body wt) intravenously (i.v.) 10 min prior to the intraperitoneal (i.p.) injection of soman (0.400-0.650 mg/kg body wt in olive oil). To avoid possible signs of poisoning, the animals received atropine sulfate (37.5 mg/kg body wt in saline) subcutaneously (s.c.) immediately after the soman administration. In the present Study, the inhibitory effect of soman was greater in plasma CaE than in hepatic microsomal CaE fraction. In addition, soman or the combination of soman-physostigmine had no remarkable effect on the microsomal CaE or P4502B activities. In spite of this, however, the microsomal CaEs might offer more protection against multiple LD50s of soman.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 23 条
[1]
AUGUSTINSSON KB, 1971, B WORLD HEALTH ORGAN, V44, P81
[2]
BOSKOVIC B, 1979, ARCH TOXICOL, V42, P207
[3]
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]
BURKE MD, 1974, DRUG METAB DISPOS, V2, P583
[6]
PROGRESS IN MEDICAL DEFENSE AGAINST NERVE AGENTS [J].
DUNN, MA ;
SIDELL, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (05) :649-652
[7]
PROPERTIES + CLASSIFICATION OF SOLUBLE ESTERASES OF HUMAN KIDNEY [J].
ECOBICHON, DJ ;
KALOW, W .
CANADIAN JOURNAL OF BIOCHEMISTRY AND PHYSIOLOGY, 1964, 42 (02) :277-&
[8]
Furlong CE, 2000, NEUROTOXICOLOGY, V21, P91
[9]
ROLE OF CARBOXYLESTERASE IN SOMAN, SARIN AND TABUN POISONING IN RATS [J].
JOKANOVIC, M .
PHARMACOLOGY & TOXICOLOGY, 1989, 65 (03) :181-184
[10]
INHIBITION OF CHOLINESTERASES BY DFP AND INDUCTION OF ORGANOPHOSPHATE-DETOXICATING ENZYMES IN RATS [J].
KALISTEKORHONEN, E ;
TORRONEN, R ;
YLITALO, P ;
HANNINEN, O .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1990, 21 (04) :527-533